Updates are available Correction dated 2018-07-06
Click to view Correction: https://doi.org/10.1007/s12185-018-2486-3
-
Authors
Ueda, Yasutaka
Obara, Naoshi
Yonemura, Yuji
Noji, Hideyoshi
Masuko, Masayoshi
Seki, Yoshinobu
Wada, Katsuya
Matsuda, Takahisa
Akiyama, Hirozumi
Ikezoe, Takayuki
Chiba, Shigeru
Kanda, Yoshinobu
Kawaguchi, Tatsuya
Shichishima, Tsutomu
Nakakuma, Hideki
Okamoto, Shinichiro
Nishimura, Jun-ichi
Kanakura, Yuzuru
Ninomiya, Haruhiko https://orcid.org/0000-0002-5431-7447
- License Information
-
More Information
Article History
Received: 29 September 2017
Revised: 24 January 2018
Accepted: 24 January 2018
First Online: 30 January 2018
Change Date: 6 July 2018
Change Type: Correction
Change Details: In the original publication of this article, Tables 2, 3 and 4 were published incorrectly. The corrected tables 2, 3 and 4 are given in the following pages.
Compliance with ethical standards
:
: Dr. Kawaguchi reported personal fees from Alexion Pharma G.K., outside the submitted work; Dr. Ueda reported personal fees from Kyowa Hakko Kirin Co.Ltd. and from Celgene, outside the submitted work; Dr. Shichishima and Dr. Yonemura, report grants from Alexion Pharma G.K., outside the submitted work; Dr. Ueda, Dr. Nishimmura, Dr. Ninomiya report grant and personal fees from Alexion Pharma G.K., during the conduct of the study; Dr. Chiba report grand from Alexion Pharma G.K., during the conduct of the study. Dr. Okamoto reports grants from Alexion Pharma G.K. and from Chugai Pharmaceutical Co. Ltd., outside the submitted work. Dr. Kanakura reports grants from Alexion Pharma G.K. and from Chugai Pharmaceutical Co. Ltd. Dr. Obara, Dr. Seki, Dr. Kanda, Dr. Nakakuma, Dr. Ikezoe, and Dr. Masuko, Dr. Noji and Dr. Wada have nothing to declare; Dr. Matsuda and Mr. Akiyama report other from Alexion Pharma G.K., outside the submitted work; Employee of Alexion Pharma G.K. and Stock/stock options in the company.
